5-Protein Biomarker for Predicting Alzheimer's Disease
Author Information
Author(s): Gómez Ravetti Martín, Moscato Pablo
Primary Institution: Centre for Bioinformatics, Biomarker Discovery & Information-Based Medicine, The University of Newcastle, Callaghan, Australia
Hypothesis
Can a 5-protein biomarker signature accurately predict Alzheimer's Disease?
Conclusion
The study identified a 5-protein biomarker signature that achieves 96% accuracy in predicting Alzheimer's Disease.
Supporting Evidence
- The 5-protein signature has the same performance as a previously proposed 18-protein signature.
- The 5-protein signature achieved 100% success in predicting Alzheimer's Disease in a test set of 92 samples.
- The study demonstrated that fewer proteins can still provide high accuracy in predicting Alzheimer's Disease.
Takeaway
Scientists found a way to tell if someone has Alzheimer's Disease by looking at just five proteins in their blood.
Methodology
The study used an integrative data analysis method involving abundance quantization, feature selection, literature analysis, and classifier selection.
Potential Biases
Potential bias due to the lack of MCI samples in the training set.
Limitations
The study did not include samples with mild cognitive impairment in the training set.
Participant Demographics
Participants included individuals diagnosed with Alzheimer's Disease and non-demented controls.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website